Assessing the Incremental Role of Novel and Emerging Risk Factors
- PMID: 20640227
- PMCID: PMC2904250
- DOI: 10.1007/s12170-010-0084-x
Assessing the Incremental Role of Novel and Emerging Risk Factors
Abstract
Many novel and emerging risk factors exhibit a significant association with cardiovascular disease, but have not been found to improve risk prediction. Statistical criteria used to evaluate such models and markers have largely relied on the receiver operating characteristic curve, which is an insensitive measure of improvement. Recently, new methods have been developed based on risk reclassification, or changes in risk strata following use of a new marker or model. Associated measures based on both calibration and discrimination have been proposed. This review describes previous methods used to evaluate models as well as the newly developed methods to evaluate clinical utility.
Figures
References
-
- Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631–2639. - PubMed
-
- Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J. Factors of risk in the development of coronary heart disease - six year follow-up experience: the Framingham Study. Ann Intern Med. 1961;55:33–50. - PubMed
-
- Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA. 2001 May 16;285(19):2486–2497. - PubMed
-
- Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med. 2006;355:2615–2617. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources